Literature DB >> 7437307

Serum levels of 8-methoxypsoralen: difference between two oral methods of administration.

L Stolk, A Kammeyer, R H Cormane, P A Van Zwieten.   

Abstract

Serum levels of 8-methoxypsoralen were determined in six human volunteers after two different methods of oral administration. 8-Methoxypsoralen was given as an aqueous solution and as powder in gelatin capsules. The area under the curve (AUC) values were higher (P < 0.05) for the solution than for the capsules, indicating a higher bioavailability. Also, the peak serum levels were higher and were reached earlier when given as a solution. Considerable individual variation of the maximum serum levels and the area under the curve values was observed for both methods of administration, but the time required to reach the maximum serum level was more predictable after administration of the solution.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7437307     DOI: 10.1111/j.1365-2133.1980.tb07265.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Comparison of serum levels and clinical results of PUVA therapy with three different dosage forms of 8-methoxypsoralen.

Authors:  A H Siddiqui; L M Stolk; R H Cormane
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

2.  New galenical form of 8-methoxypsoralen in photochemotherapy of psoriasis.

Authors:  A Langner; H Wolska
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

3.  Comments on the paper by V. Nitsche et al.: 8-Methoxypsoralen (8-MOP) in neuer galenischer Zubereitung und seine Beziehung zum 8-MOP-Serumspiegel. 8-Methoxypsoralen (8-MOP)--a new galenic form and its relation to 8-MOP serum levels.

Authors:  A H Siddiqui
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

4.  Difference in bioavailability between two brands of 8-methoxypsoralen and its impact on the clinical response in psoriatic patients.

Authors:  M J Herfst; F A De Wolff
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

Review 5.  Clinical pharmacokinetics of methoxsalen and other psoralens.

Authors:  F A de Wolff; T V Thomas
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

6.  Pharmacokinetics of 8-methoxypsoralen in serum and suction blister fluid.

Authors:  J Lauharanta; T Juvakoski; L Kanerva; A Lassus
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.